Metropolis Healthcare · NSE: METROPOLIS · BSE: 542650
Q3 FY21 results · Oct–Dec 2020
Metropolis Healthcare reported revenue from operations of ₹274.78 crore (up 23.3% from Q3 FY20) and net profit of ₹58.64 crore (up 39.6% from Q3 FY20) for Q3 FY21 (Oct–Dec 2020), on a consolidated basis.
| Item | Q3 FY21 | Q3 FY20 | YoY | Q2 FY21 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 274.78 | 222.85 | +23.3% | 288.35 | −4.7% |
| Other income | 3.74 | 2.19 | +70.9% | 3.08 | +21.3% |
| Total income | 278.52 | 225.04 | +23.8% | 291.44 | −4.4% |
| Profit before tax | 77.77 | 52.80 | +47.3% | 81.39 | −4.5% |
| Net profit for the period | 58.64 | 42.01 | +39.6% | 60.52 | −3.1% |
| Attributable to shareholders of the company | 58.57 | 42.07 | +39.2% | — | — |
| EPS, basic (₹) | 11.50 | 8.38 | +37.2% | 11.88 | −3.2% |
| Net margin (%) | 21.3 | 18.9 | 21.0 |
| Item | Q3 FY21 | Q3 FY20 | YoY | Q2 FY21 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 224.43 | 172.91 | +29.8% | 242.55 | −7.5% |
| Other income | 2.37 | 1.78 | +32.5% | 1.83 | +29.6% |
| Total income | 226.79 | 174.69 | +29.8% | 244.37 | −7.2% |
| Profit before tax | 64.49 | 39.99 | +61.3% | 70.09 | −8.0% |
| Net profit for the period | 48.70 | 32.30 | +50.8% | 52.36 | −7.0% |
| EPS, basic (₹) | 9.56 | 6.44 | +48.4% | 11.52 | −17.0% |
| Net margin (%) | 21.7 | 18.7 | 21.6 |
Consolidated
- Filed with BSE
- 11 Feb 2021, 13:25 IST
- Board meeting
- 10 Feb 2021
- Period
- 01 Oct 2020 to 31 Dec 2020
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 11 Feb 2021, 13:25 IST
- Board meeting
- 10 Feb 2021
- Period
- 01 Oct 2020 to 31 Dec 2020
- Review status
- Unaudited
- Source
- XBRL filing on BSE